PANEL DISCUSSION: Legislative & Regulatory Overview of the Microbiome Arena in the United States
Time: 9:00 am
day: Day Two
Speakers:
Ken Blount, PhD, is a seasoned director of collaborative research programs in biotech, pharma, clinical, and academic research settings, and his scientific expertise includes antibiotics discovery and development, fecal microbiome analysis, translational medical oncology, and RNA-targeting therapeutics. Prior to joining Rebiotix, a Ferring Company, Dr. Blount coordinated translational urologic oncology research for the Yale Cancer…Read more
